iBio, Inc. IBIO
Set alert
0.81 USD +0.01 +1.39%
As of Nov 3, 12:38 PM ET
0.7902 Day range 0.8359
0.71 52-week range 3.07
- YTD
- -57.98%
- 1 year
- -53.92%
- Open
- 0.80
- Prev close
- 0.7999
- Mkt cap
- 40.29M
- Vol
- 107.30K
- Avg vol
- 704.61K
- EPS
- -0.32
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7902
- High
- 0.8359
- Forward P/E
- -1.44
- Beta
- 0.00
- Short ratio
- 1.92
- Inst. own
- 31.49%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 14, 2025
- 50-d avg
- 2.60
- 200-d avg
- 2.17
- 1y target
- 3.60
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 3.60
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 2
- 2 months ago 2
- 3 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.45 | -0.45 – -0.45 | 0.00 | 0.0% | 0 | 0.0% | 1 |
| Next quarter | -0.39 | -0.39 – -0.39 | -0.97899 | +60.2% | 0 | 0.0% | 1 |
| Current year | -1.74 | -1.74 – -1.74 | -4.29 | +59.5% | 0 | -100.0% | 1 |
| Next year | -2.05 | -2.05 – -2.05 | -1.74 | -17.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2024 | LUCID CAPITAL MARKETS | Initiated | — | Buy |
| Jul 22, 2024 | Brookline Capital | Initiated | — | Buy |
| Jun 3, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 28, 2024 | Chardan Capital | Initiated | — | Buy |